How can Cytokine-induced killer cells overcome CAR-T cell limits
The successful treatment of patients affected by B-cell malignancies with Chimeric Antigen Receptor (CAR)-T cells represented a breakthrough in the field of adoptive cell therapy (ACT). However, CAR-T therapy is not an option for every patient, and several needs remain unmet. In particular, the prod...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Revisão |
| Sprog: | engelsk |
| Udgivet: |
2023
|
| Online adgang: | https://doi.org/10.3389/fimmu.2023.1229540 https://www.frontiersin.org/articles/10.3389/fimmu.2023.1229540/pdf |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|